Harith Rajagopalan - Feb 6, 2024 Form 4 Insider Report for Fractyl Health, Inc. (GUTS)

Role
Chief Executive Officer, Director
Signature
/s/ Lisa A. Davidson, Attorney-in-fact
Stock symbol
GUTS
Transactions as of
Feb 6, 2024
Transactions value $
$0
Form type
4
Date filed
2/8/2024, 04:37 PM
Previous filing
Feb 1, 2024
Next filing
Nov 13, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GUTS Common Stock Conversion of derivative security +6.52K +0.99% 663K Feb 6, 2024 Direct F1
transaction GUTS Common Stock Conversion of derivative security +2.8K +0.97% 292K Feb 6, 2024 By 2016 Irrevocable Trust F1
holding GUTS Common Stock 18.6K Feb 6, 2024 By 2021 Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GUTS Series A Preferred Stock Conversion of derivative security -14K -100% 0 Feb 6, 2024 Common Stock 6.52K Direct F1
transaction GUTS Series A Preferred Stock Conversion of derivative security -6K -100% 0 Feb 6, 2024 Common Stock 2.8K By 2016 Irrevocable Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock.